Wayne Godfrey, MD, is a hematologist and medical oncologist with subspecialty expertise in bone marrow transplantation and cancer immunotherapy. He serves as Chief Medical Officer at Janux Therapeutics, where he leads clinical development of next-generation immunotherapies. Clinically, Dr. Godfrey focuses on hematology/medical oncology, bone marrow and cellular transplantation, and immuno-oncology. His research interests center on cancer immunology and immune regulation, translational immuno-oncology, and the clinical development of novel biologics and cell-based therapies. An experienced physician-scientist and industry leader, he has held senior roles including chief medical officer and head of clinical development at multiple biotechnology companies, guiding late-stage programs to regulatory approvals in oncology and initiating first-in-human studies of T cell–engaging bispecific antibodies. He earned his medical degree from Washington University School of Medicine in St. Louis, completed an internal medicine residency at Stanford University, and pursued fellowships in clinical immunology, hematology, and bone marrow transplantation at Stanford.
Medical School
Residency
Fellowship